Charles W. Taylor
Expertise in
51
conditions

Dr. Charles W. Taylor

Hematology | Oncology
12697 E 51st St, 
Tulsa, OK 
Accepting New Patients
48 Years of Experience
Expertise in
51
conditions
12697 E 51st St, 
Tulsa, OK 

Overview

Charles W. Taylor, MD, is an independent medical oncologist at Ascension St. John in Tulsa, Oklahoma. Dr. Taylor diagnoses and treats cancer using medications, such as chemotherapy. Every appointment with Dr. Taylor starts with a conversation. He takes the time to answer all your questions - big and small.

Dr. Taylor is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Lung Cancer.

Dr. Taylor is board certified in The American Board Of Internal Medicine - Medical Oncology and The American Board Of Internal Medicine - Internal Medicine. He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 1 clinical trial. Dr. Taylor is currently accepting new patients.

Graduate Institution

University Of OK At Oklahoma City College Of Medicine, 1978

Residency

University of OK at Oklahoma City College of Medicine

Specialties

Hematology
Oncology

Licenses

Internal Medicine in OK

Board Certifications

The American Board Of Internal Medicine - Medical Oncology
The American Board Of Internal Medicine - Internal Medicine

Fellowships

University of Arizona College of Medicine

Hospital Affiliations

Ascension St. John Jane Phillips
Ascension St. John Medical Center
St John Owasso
Ascension St John Jane Phillips
Ascension St John Medical Center
Cherokee Nation W W Hastings Indian Hospital
Saint Francis Hospital, Inc

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
CommunityCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Oklahoma Cancer Specialist and Research Institute
12697 E 51st St, Tulsa, OK 74146
Other Locations
Oklahoma Cancer Specialists And Research Institute
12697 E 51st St, Tulsa, OK 74146

Additional Areas of Focus

Dr. Taylor has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2 Negative, HR Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated With a Taxane
A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2 Negative, HR Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated With a Taxane
Enrollment Status: Terminated
Publish Date: July 30, 2021
Intervention Type: Drug
Study Drugs: Tesetaxel and Capecitabine, Capecitabine
Study Phase: Phase 3

2 Total Publications

APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial.
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trial.
Journal: Cancer management and research
Published: June 06, 2017
Similar Doctors
Expertise in
45
conditions
Dr. Jihad Khattab
Hematology | Oncology
Expertise in
45
conditions
Dr. Jihad Khattab
Hematology | Oncology
Referral may be required

Saint Francis Cancer Center

11212 East 48th Street, 
Tulsa, OK 
 (0.9 miles away)
918-556-3000
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Jihad Khattab is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Khattab is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Khattab is currently accepting new patients.

Expertise in
48
conditions
Dr. Muhammad A. Janjua
Hematology | Oncology
Expertise in
48
conditions
Dr. Muhammad A. Janjua
Hematology | Oncology
Referral may be required

Saint Francis Cancer Center

11212 East 48th Street, 
Tulsa, OK 
 (0.9 miles away)
918-556-3000
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Muhammad Janjua is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Janjua is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Familial Pancreatic Cancer, Aplastic Anemia, Immune Thrombocytopenic Purpura (ITP), and Bone Marrow Aspiration. Dr. Janjua is currently accepting new patients.

Expertise in
28
conditions
Dr. Matthew D. Armstrong
Hematology | Oncology
Expertise in
28
conditions
Dr. Matthew D. Armstrong
Hematology | Oncology
Referral may be required

Saint Francis Cancer Center

11212 East 48th Street, 
Tulsa, OK 
 (0.9 miles away)
918-556-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Matthew Armstrong is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Armstrong is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma. Dr. Armstrong is currently accepting new patients.

Frequently Asked Questions about Dr. Charles W. Taylor

How do I make an appointment with Dr. Charles W. Taylor?

You can book an appointment with Dr. Charles W. Taylor by calling their office at 918-505-3200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Charles W. Taylor a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Charles W. Taylor is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Charles W. Taylor specialize in?

While Dr. Charles W. Taylor is a Hematology, they have specific expertise in Paget Disease of the Breast, Breast Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Charles W. Taylor participate in research or clinical trials?

Yes. Dr. Charles W. Taylor has published 2 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Charles W. Taylor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Charles W. Taylor accept my insurance?

Dr. Charles W. Taylor accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 918-505-3200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Taylor's expertise for a condition
ConditionClose
    View All 11 Distinguished Conditions
    View All 40 Advanced Conditions
    View All 101 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile